RMD Dec 2024 290.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 12:29PM EDT
Loading interactive chart…
- Zacks
3 Reasons Growth Investors Will Love ResMed (RMD)
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Teleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.
- Zacks
BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase
BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.
© 2024 Yahoo. All rights reserved.